Partners
Trusted by the institutions that set the standard.
15 research institutions and enterprise customers across Europe, the UK, the US, and Canada.
Partners
The organizations changing what's possible for people with diabetes.
Fifteen years of listening to people with diabetes. Half a million surveys. dQ&A exists to make sure the patient voice shapes the decisions that affect them most.
An international non-profit accelerating life-changing therapies for Type 1 diabetes. INNODIA bridges research, clinical practice, and pharma to make innovative T1D treatments accessible.
OneTwenty believes the gap between a diabetes diagnosis and a life fully lived shouldn't be as wide as it is. They build the tools that help close it.
A venture fund backing early-stage companies tackling Type 1 diabetes. 1921.vc uses Syno for scientific due diligence — combining deep patient networks with AI-powered research analysis to find the smartest bets in T1D.
From our research partners
"An invaluable resource for advancing closed-loop system research, offering access to data and tools that can help us drive innovation and outcomes in diabetes management."
"With the Diabetes Cockpit dataset and tools offered by Syntactiq, we have new avenues for understanding the intricate relationship between activity, exercise, and diabetes management, driving innovation in personalized care."
"Syntactiq.ai's sleep data is a game-changer for understanding how sleep impacts diabetes management, especially for personalized care."
"Answering key questions in diabetes is often hard due to lack of data. Working with Lukas has been the opposite — rich context, open sharing, and a friendly, accessible team."
"Syntactiq's vast real-world dataset on insulin and glucose is enabling us to explore new approaches and develop algorithms in ways that were previously inaccessible to us."
"An invaluable resource for advancing closed-loop system research, offering access to data and tools that can help us drive innovation and outcomes in diabetes management."
"With the Diabetes Cockpit dataset and tools offered by Syntactiq, we have new avenues for understanding the intricate relationship between activity, exercise, and diabetes management, driving innovation in personalized care."
"Syntactiq.ai's sleep data is a game-changer for understanding how sleep impacts diabetes management, especially for personalized care."
"Answering key questions in diabetes is often hard due to lack of data. Working with Lukas has been the opposite — rich context, open sharing, and a friendly, accessible team."
"Syntactiq's vast real-world dataset on insulin and glucose is enabling us to explore new approaches and develop algorithms in ways that were previously inaccessible to us."
15 research partnerships across Europe, the UK, the US, and Canada.
Better tools. Faster science. Better lives.
That's what we're building together.
Used at 15 research institutions across 3 continents.